Varicella vaccination still cost-effective despite hypothesized shortened asthma onset – Healio

Varicella vaccination still cost-effective despite hypothesized shortened asthma onset
Healio
Recent findings published in The Pediatric Infectious Disease Journal showed that chickenpox vaccination in the United States remained cost-effective even when considering a hypothesized shortened onset of asthma.